In this study, we investigate the utility of monitoring serum antibody levels against E.CPS as a disease survival predictor and compare it with LBP (BT marker), Mac-2, as a cell-associated macrophage antigen, binding protein (Mac-2 bp; hepatocyte damage or hepatic condition marker) (13), Aleuria aurantia lectin-haptoglobin (AAL-Hp; hepatocyte damage or hepatic condition marker) (14) and albumin-bilirubin (ALBI; hepatic functional reserve marker) score in patients with CLD. Here, LGALS3 is linked to congenital secretory chloride diarrhea 1.